InnoCare Pharma Grants Shares Under Incentive Scheme

InnoCare Pharma Ltd. (HK:9969) has released an update.

InnoCare Pharma Ltd. has granted 9,870,200 restricted shares to 79 participants under its 2024 RMB Share Incentive Scheme, representing around 0.56% of the company’s total issued shares. The grants, which include allocations to key executives, are priced at RMB6.65 per share and are subject to a structured vesting period and performance assessments. This move aims to incentivize the company’s leadership and key employees, potentially impacting future stock performance positively.

For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.